Servo-Controlled Liquid Ventilation for Homogeneous Agent Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current respiratory therapies for preterm infants and patients with pulmonary disorders are inadequate in maintaining gas exchange, optimizing lung function, and minimizing ventilation pressures, particularly during liquid ventilation, where the distribution of breathable liquids and biological agents is challenging due to unknowns in lung mechanics and gas exchange.

Innovation Solution

A method involving a servo-control unit to establish a baseline ventilation pattern, adjust lung volume, and introduce biological agents at optimal tidal volumes and inspiratory times, ensuring homogeneous distribution and maintaining therapeutic concentrations through a delivery system that includes a liquid reservoir, pump, gas exchange filter, and BA injector, optimized by a microprocessor for effective gas exchange and lung protection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If breathable liquids are administered to increase lung volume above baseline, then gas exchange is enhanced and lung function is optimized, but the distribution of biological agents becomes challenging due to unknowns in lung mechanics and gas exchange

Engineering Contradiction:
Improvegas exchangeVSAvoiddistribution of biological agents
Core Design Contradiction:
ReliabilityVSDifficulty of detecting and measuring

Solution Approach 1:

The system employs a servo-control unit that continuously monitors ventilatory parameters and adjusts the delivery of breathable liquids and biological agents in real-time. This feedback mechanism allows the system to adapt to changing lung mechanics and gas exchange conditions, ensuring optimal distribution of biological agents while maintaining reliable gas exchange.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The invention dynamically adjusts ventilation patterns, tidal volumes, and inspiratory times based on real-time patient response. The system transitions between baseline and increased ventilation patterns as needed, allowing optimal delivery of biological agents at specific tidal volumes while maintaining gas exchange effectiveness.

Inventive Principle:
Principle #15Dynamics

2Reliability

If additional breathable liquid is added to increase lung volume, then gas exchange is improved, but ventilation pressures increase

Engineering Contradiction:
Improvegas exchangeVSAvoidventilation pressures
Core Design Contradiction:
ReliabilityVSStress or pressure

Solution Approach 1:

The system dynamically adjusts ventilation parameters including tidal volume and inspiratory time based on real-time monitoring. By optimizing these parameters, the system achieves effective gas exchange while minimizing ventilation pressures and avoiding lung injury.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The invention changes ventilatory parameters such as tidal volume, inspiratory time, and ventilation pattern to optimize gas exchange. The servo-control unit adjusts these parameters to maintain effective carbon dioxide elimination and minimize resistive pressures.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If biological agents are introduced at mid-tidal volume, then delivery effectiveness is optimized, but the system complexity increases

Engineering Contradiction:
Improvebiological agent deliveryVSAvoiddelivery system control
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The servo-control unit monitors ventilatory parameters and automatically determines the optimal timing for biological agent introduction. This feedback-based control simplifies the complex task of timing agent delivery by using real-time data to trigger administration at the optimal moment during the ventilation cycle.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system establishes a baseline ventilation pattern before introducing biological agents. This preliminary setup allows the system to optimize subsequent agent delivery by building upon a stable foundation of controlled ventilation, reducing the overall complexity of coordination.

Inventive Principle:
Principle #10Preliminary action

4Reliability

If ventilation pattern is returned to baseline after biological agent delivery, then lung function is maintained, but treatment duration increases

Engineering Contradiction:
Improvelung functionVSAvoidtreatment duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The system dynamically transitions between baseline and increased ventilation patterns based on treatment requirements. After biological agent delivery, the system returns to baseline ventilation to maintain lung function while minimizing the duration of high-ventilation support, thereby reducing overall treatment time.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances gas exchange, optimizes lung function, minimizes ventilation pressures, and ensures effective delivery of biological agents, improving treatment outcomes for pulmonary disorders by maintaining uniform concentrations and reducing waste and costs associated with high-cost breathable liquids and agents.

Implementation Method 1

Gas is transported in dissolved form, the gas-liquid interface at the alveolar surface is eliminated

Methodology Applied
Scientific EffectDissolution: Absorption (physical)

Implementation Method 2

a pump is used to pump a warmed and oxygenated PFC liquid from a liquid reservoir through an inspiratory valve

Methodology Applied
Scientific EffectPumping: Pump

Data Source

PatentUS7909031B2Process for transient and steady state delivery of biological agents to the lung via breathable liquids
Publication Date: 2011.03.22 TEMPLE UNIV
  • US7909031B2 patent drawing
  • US7909031B2 patent drawing
  • US7909031B2 patent drawing

AI summary

The present invention includes a transient method of delivering a biological agent in a breathable liquid to a lung of a patient. The present invention includes a steady state method of delivering a biological agent in a breathable liquid to a lung of a patient. The steps of both the transient delivery method and the steady state delivery method can be controlled by a servo-control unit. A supplementary biological agent delivery step can be performed in both the transient method of delivering a biological agent and the steady state method of delivering a biological agent.